​
​

Inhibrx Biosciences Ownership | Who Owns Inhibrx Biosciences?

OverviewRevenueFinancialsChart

Inhibrx Biosciences Ownership Summary

Inhibrx Biosciences is owned by 0.06% institutional investors, 23.55% insiders, and 76.39% retail investors. Financial gravity asset management is the largest institutional shareholder, holding 0% of INBX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.32% of its assets in Inhibrx Biosciences shares.

INBX Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockInhibrx Biosciences0.06%23.55%76.39%
SectorHealthcare Stocks 46.80%8.14%45.06%
IndustryBiotech Stocks 44.70%7.99%47.31%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Financial gravity asset management---
Price t rowe associates inc /md/---
Geode capital management---
Voya investment management---
Proshare advisors---
Wetherby asset management---
Arrowmark colorado---
Yakira capital management---
Legal & general group---
Scientech research---

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Financial gravity asset management---
Price t rowe associates inc /md/---
Geode capital management---
Voya investment management---
Proshare advisors---
Wetherby asset management---
Arrowmark colorado---
Yakira capital management---
Legal & general group---
Scientech research---

Top Buyers

HolderShares% AssetsChange
Financial gravity asset management---2.00
Rothschild investment---5.00
Nelson, van denburg & campbell wealth management group---8.00
Farther finance advisors---13.00
Eversource wealth advisors---25.00

Top Sellers

HolderShares% AssetsChange
Viking global investors lp---7.15M
Perceptive advisors---4.26M
Blackrock---2.75M
Ra capital management---2.63M
State street---2.42M

Sold Out

HolderChange
Financial gravity asset management-2.00
Rothschild investment-5.00
Nelson, van denburg & campbell wealth management group-8.00
Farther finance advisors-13.00
Eversource wealth advisors-25.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 20242-98.47%33,090-99.91%-0.00%--100.00%1-97.37%
Mar 31, 2024131-2.96%38,256,224-5.67%811.10%666.45%38-11.63%
Dec 31, 202313521.62%40,555,7103.94%861.08%6212.73%4322.86%
Sep 30, 20231111.83%39,019,1678.34%891.31%551.85%3512.90%
Jun 30, 2023109-0.91%36,015,505-1.76%821.17%545.88%31-13.89%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.22M2.32%94.03K
Vanguard Institutional Extnd Mkt Idx Tr394.10K0.75%-76.00
The Merger Fund A198.51K0.38%198.51K
Vanguard Russell 2000 ETF129.24K0.25%1.43K
Meridian Small Cap Growth Legacy123.63K0.24%-39.95K
ArrowMark Small Cap Gro123.63K0.24%-39.95K
NT R2000 Index Fund - NL95.63K0.18%-1.93K
NT R2000 Index Fund - DC - NL - 275.94K0.14%-886.00
NT R2000 Growth Index Fund - NL68.25K0.13%-
iShares Russell 2000 Small-Cap Idx Instl64.02K0.12%-

Recent Insider Transactions

DateNameRoleActivityValue
Oct 03, 2024Vuori Kristiina MD-Buy$100.00K
Sep 12, 2024Lappe Mark Chief Executive OfficerBuy$405.79K
Sep 16, 2024Lappe Mark Chief Executive OfficerBuy$223.32K
Sep 10, 2024Vuori Kristiina MD-Buy$2.69K
Sep 11, 2024Vuori Kristiina MD-Buy$97.31K

Insider Transactions Trends

DateBuySell
2024 Q37-
2024 Q2-1
2024 Q1--
2023 Q32-
2023 Q2--

INBX Ownership FAQ

Who Owns Inhibrx Biosciences?

Inhibrx Biosciences shareholders are primarily institutional investors at 0.06%, followed by 23.55% insiders and 76.39% retail investors. The average institutional ownership in Inhibrx Biosciences's industry, Biotech Stocks , is 44.70%, which Inhibrx Biosciences falls below.

Who owns the most shares of Inhibrx Biosciences?

Inhibrx Biosciences’s largest shareholders are Financial gravity asset management (0 shares, 0%), Price t rowe associates inc /md/ (0 shares, 0%), and Geode capital management (0 shares, 0%). Together, they hold 0% of Inhibrx Biosciences’s total shares outstanding.

Does Blackrock own Inhibrx Biosciences?

BlackRock is not among the top 10 institutional shareholders of Inhibrx Biosciences.

Who is Inhibrx Biosciences’s biggest shareholder by percentage of total assets invested?

Financial gravity asset management is Inhibrx Biosciences’s biggest shareholder by percentage of total assets invested, with 0% of its assets in 0 Inhibrx Biosciences shares, valued at 0$.

Who is the top mutual fund holder of Inhibrx Biosciences shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Inhibrx Biosciences shares, with 2.32% of its total shares outstanding invested in 1.22M Inhibrx Biosciences shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools